JPJoan Albert Pou

Joan Albert Pou

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Joan Albert Pou has a total of 32 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Geographical Distribution and Social Justice of the COVID‐19 Pandemic: The Case of Palma (Balearic Islands)

    by Maurici Ruiz‐Pérez, Alexandre Moragues, Joana Maria Seguí‐Pons, Josep Muncunill, Albert Pou Goyanes, Antoni Colom Fernández

    The spatial distribution of the COVID‐19 infection rate in the city of Palma (Balearic Islands) is analyzed from the geolocation of positive cases by census tract and its relationship with socioeconomic variables is evaluated. Data on infections have been provided by the Health Service of the Ministry of Health and Consumption of the Government of the Balearic Islands. The study combines several methods of analysis: spatial autocorrelation, calculation of the Gini index and least squares regression, and weighted geographical regression. The results show that the pandemic comprised five waves in the March 2020–March 2022 period, corresponding to the months of April 2020, August 2020, December 2020, July 2021, and January 2022. Each wave shows a particular geographical distribution pattern, however, the second and third waves show higher levels of spatial concentration. In this sense, the second wave, affecting the peripheral neighborhoods of the eastern part of the city. The Gini index confirms geographical imbalances in the distribution of infections in the first waves of the pandemic. In addition, the regression models indicate that the most significant socioeconomic variables in the prediction of COVID‐19 infection are average income, percentage of children under 18 years of age, average size of the household, and percentage of single‐person households. The study shows that economic imbalances in the city have had a clear influence on the spatial pattern of pandemic distribution. It shows the need to implement spatial justice policies in income distribution to balance the effects of the pandemic.


  • Open Access

    Predictive Immunological, Virological, and Routine Laboratory Markers for Critical COVID-19 on Admission

    by Mercedes García-Gasalla, Juana M. Ferrer, Pablo A. Fraile-Ribot, Adrián Ferre-Beltrán, Adrián Rodríguez, Natalia Martínez-Pomar, Luisa Ramon-Clar, Amanda Iglesias, Inés Losada-López, Francisco Fanjul, et al.

    Background. Early identification of COVID-19 patients at risk of critical illness is a challenging endeavor for clinicians. We aimed to establish immunological, virological, and routine laboratory markers, which, in combination with clinical information, may allow identifying such patients. Methods. Blood tests to measure neutrophil/lymphocyte ratio (NLR) and levels of ferritin, CRP, D-dimer, complement components (C3 and C4), cytokines, and lymphocyte subsets, as well as SARS-Cov-2 RT-PCR tests, were performed in COVID-19-confirmed cases within 48hours of admission. RT-PCR cycle threshold (Ct) values from oropharyngeal or nasopharyngeal swabs were determined on the day of admission. Symptom severity was categorized as mild (grade 1), severe (grade 2), or critical (grade 3). Results. Of 120 patients who were included, 49 had mild, 32 severe, and 39 critical COVID-19. Levels of ferritin >370ng/mL (OR 16.4, 95 CI 5.350.8), D-dimer >440ng/mL (OR 5.45, 95 CI 2.3612.61), CRP >7.65mg/dL (OR 11.54, 95 CI 4.330.8), NLR >3.77 (OR 13.4, 95 CI 4.341.1), IL-6 >142.5pg/mL (OR 8.76, 95 CI 3.5621.54), IL-10 >10.8pg/mL (OR 16.45, 95 CI 5.3250.81), sIL-2rα (sCD25) >804.5pg/mL (OR 14.06, 95 CI 4.5643.28), IL-1Ra >88.4pg/mL (OR 4.54, 95 CI 2.0310.17), and IL-18 >144pg/mL (OR 17.85, 95 CI 6.5448.78) were associated with critical COVID-19 in the univariate age-adjusted analysis. This association was confirmed in the multivariate age-adjusted analysis only for ferritin, CRP, NLR, IL-10, sIL-2rα, and IL-18. T, B, and NK cells were significantly decreased in critical patients. SARS-CoV-2 was not detected in blood except in 3 patients who had indeterminate results. RT-PCR Ct values from oropharyngeal or nasopharyngeal swabs on admission were not related to symptom severity. Conclusion. Ferritin, D-dimer, CRP, NLR, cytokine (IL-18 and IL-10), and cytokine receptor (IL-6, IL1-Ra, and sCD25) test results combined with clinical data can contribute to the early identification of critical COVID-19 patients.


  • Open Access

    Urine biomarkers for the prediction of mortality in COVID-19 hospitalized patients

    by Daniel Morell-Garcia, David Ramos-Chavarino, Josep M. Bauça, Paula Argente del Castillo, Maria Antonieta Ballesteros-Vizoso, Luis García de Guadiana-Romualdo, Cristina Gómez-Cobo, J. Albert Pou, Rocío Amezaga-Menéndez, Alberto Alonso-Fernández, et al.

    Risk factors associated with severity and mortality attributable to COVID-19 have been reported in different cohorts, highlighting the occurrence of acute kidney injury (AKI) in 25% of them. Among other, SARS-CoV-2 targets renal tubular cells and can cause acute renal damage. The aim of the present study was to evaluate the usefulness of urinary parameters in predicting intensive care unit (ICU) admission, mortality and development of AKI in hospitalized patients with COVID-19. Retrospective observational study, in a tertiary care hospital, between March 1st and April 19th, 2020. We recruited adult patients admitted consecutively and positive for SARS-CoV-2. Urinary and serum biomarkers were correlated with clinical outcomes (AKI, ICU admission, hospital discharge and in-hospital mortality) and evaluated using a logistic regression model and ROC curves. A total of 199 COVID-19 hospitalized patients were included. In AKI, the logistic regression model with a highest area under the curve (AUC) was reached by the combination of urine blood and previous chronic kidney disease, with an AUC of 0.676 (95%CI 0.512–0.840; p = 0.023); urine specific weight, sodium and albumin in serum, with an AUC of 0.837 (95% CI 0.766–0.909; p < 0.001) for ICU admission; and age, urine blood and lactate dehydrogenase levels in serum, with an AUC of 0.923 (95%CI 0.866–0.979; p < 0.001) for mortality prediction. For hospitalized patients with COVID-19, renal involvement and early alterations of urinary and serum parameters are useful as prognostic factors of AKI, the need for ICU admission and death.